The Benefits of Clinical Trials for Triple Negative Breast Cancer

Listen Now

Topics Covered

• The Treatment of Triple Negative Breast Cancer
• Why Clinical Trials are Important as a Treatment Option for Triple Negative Breast Cancer
• What Happens in a Clinical Trial
• Stages of Clinical Trials
• New Research in the Treatment of Triple Negative Breast Cancer (TNBC)
• Investigational New Drugs in Clinical Trials
• The Meaning of Informed Consent
• Benefits & Risks of Participation
• How & Where Clinical Trials are Conducted
• How to Participate in Clinical Trials
• Specific Questions to Ask Your Health Care Team about Clinical Trials
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
• Accessing Resources for Clinical Trials
• Questions for Our Panel of Experts

Our Panel of Experts

Kamel Abou Hussein, MD

Assistant Professor of Medicine, Cooper Medical School of Rowan University, Adjunct Assistant Professor, Department of Breast Medical Oncology, MD Anderson Cancer Center, Co-Director of the Janet Knowles Breast Cancer Program, Director of Breast Cancer Clinical Trials, MD Anderson Cancer Center at Cooper

Marcela Mazo Canola, MD

Assistant Professor of Medicine, Division of Hematology – Oncology, Breast Medical Oncology, UT Health San Antonio Mays Cancer Center

Hayley Dinerman, JD

Co-Founder and Executive Director, Triple Negative Breast Cancer Foundation®

Cassie Spector, MSW

Breast and Gynecological Cancers Program Coordinator, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on January 15, 2025.